PharmaShots | Incisive News in 3 Shots

Subscribe Now

Muscle-Invasive

Roche Reports Results of Tecentriq (atezolizumab) in P-III IMvigor010 Study for Patients with Muscle-Invasive Urothelial Cancer

Roche Reports Results of Tecentriq (atezolizumab) in P-III IMvigor010 Study for Patients with Muscle-Invasive Urothelial Cancer

January 24, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us